Study Summary
This trial will test the effects of exercise on sarcopenia and frailty.
- End Stage Liver Disease
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: baseline, 3 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Home based program
1 of 2
Pulmonary Rehabilitation
1 of 2
Active Control
50 Total Participants · 2 Treatment Groups
Primary Treatment: Home based program · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the magnitude of individuals registered for this clinical experiment?
"Affirmative. According to information found on clinicaltrials.gov, this trial has been actively looking for participants since February 1st 2018 and was last updated on November 24th 2022 - the researchers are aiming to recruit 50 candidates from 2 different medical sites." - Anonymous Online Contributor
Does the public have access to this research opportunity at present?
"That is correct. Clinicaltrials.gov reflects that this clinical trial, which was first published on February 1st 2018, is actively recruiting patients for participation. The study requires 50 participants to be enrolled from two distinct sites." - Anonymous Online Contributor